Anti-™ED4/ ERS25/ GMP25iso functional antibody

Anti-™ED4/ ERS25/ GMP25iso functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to ™ED4/™ED4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0509-Ab-1/ GM-Tg-hg-SE0509-Ab-2Anti-Human ™ED4 monoclonal antibodyHuman
GM-Tg-rg-SE0509-Ab-1/ GM-Tg-rg-SE0509-Ab-2Anti-Rat ™ED4 monoclonal antibodyRat
GM-Tg-mg-SE0509-Ab-1/ GM-Tg-mg-SE0509-Ab-2Anti-Mouse ™ED4 monoclonal antibodyMouse
GM-Tg-cynog-SE0509-Ab-1/ GM-Tg-cynog-SE0509-Ab-2Anti-Cynomolgus/ Rhesus macaque ™ED4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0509-Ab-1/ GM-Tg-felg-SE0509-Ab-2Anti-Feline ™ED4 monoclonal antibodyFeline
GM-Tg-cang-SE0509-Ab-1/ GM-Tg-cang-SE0509-Ab-2Anti-Canine ™ED4 monoclonal antibodyCanine
GM-Tg-bovg-SE0509-Ab-1/ GM-Tg-bovg-SE0509-Ab-2Anti-Bovine ™ED4 monoclonal antibodyBovine
GM-Tg-equg-SE0509-Ab-1/ GM-Tg-equg-SE0509-Ab-2Anti-Equine ™ED4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0509-Ab-1/ GM-Tg-hg-SE0509-Ab-2; GM-Tg-rg-SE0509-Ab-1/ GM-Tg-rg-SE0509-Ab-2;
GM-Tg-mg-SE0509-Ab-1/ GM-Tg-mg-SE0509-Ab-2; GM-Tg-cynog-SE0509-Ab-1/ GM-Tg-cynog-SE0509-Ab-2;
GM-Tg-felg-SE0509-Ab-1/ GM-Tg-felg-SE0509-Ab-2; GM-Tg-cang-SE0509-Ab-1/ GM-Tg-cang-SE0509-Ab-2;
GM-Tg-bovg-SE0509-Ab-1/ GM-Tg-bovg-SE0509-Ab-2; GM-Tg-equg-SE0509-Ab-1/ GM-Tg-equg-SE0509-Ab-2
Products NameAnti-™ED4 monoclonal antibody
Formatmab
Target Name™ED4
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-™ED4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0509-Ag-1Recombinant multi-species ™ED4/ ERS25/ GMP25iso protein
    ORF Viral VectorvGMLP002599human ™ED4 Lentivirus particle
    ORF Viral VectorpGMLP002599human ™ED4 Lentivirus plasmid
    ORF Viral VectorpGMLPm001573mouse Tmed4 Lentivirus plasmid
    ORF Viral VectorvGMLPm001573mouse Tmed4 Lentivirus particle


    Target information

    Target IDGM-SE0509
    Target Name™ED4
    Gene ID222068,103694,305502,699105,475498,101095809,508729,100065195
    Gene Symbol and Synonyms1110014L17Rik,ERS25,GMP25iso,HNLF,p24a3,p24alpha3,RGD1306319,™ED4
    Uniprot AccessionQ7Z7H5
    Uniprot Entry Name™ED4_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000158604
    Target ClassificationN/A

    The target: ™ED4, gene name: ™ED4, also named as ERS25, GMP25iso, HNLF, p24a3, p24alpha3. Involved in positive regulation of I-kappaB kinase/NF-kappaB signaling. Predicted to be located in endoplasmic reticulum membrane. Predicted to be integral component of membrane. Predicted to be active in several cellular components, including COPII-coated ER to Golgi transport vesicle; Golgi apparatus; and endoplasmic reticulum-Golgi intermediate compartment. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.